TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Shire Biotech Norway AS
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
20,605
|
13,639
|
12,032 |
Financial expenses |
25
|
-3
|
39 |
Earnings before taxes |
981
|
651
|
537 |
Total assets |
6,505
|
4,763
|
3,108 |
Current assets |
6,487
|
4,733
|
3,104 |
Current liabilities |
4,193
|
3,277
|
1,915 |
Equity capital |
2,312
|
1,486
|
1,191 |
- share capital |
105
|
96
|
105 |
Employees (average) |
6
|
5
![]() |
5 |
Shareholders | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
35.5%
|
31.2%
|
38.3% |
Turnover per employee |
3,434
|
2,728
|
2,406 |
Profit as a percentage of turnover |
4.8%
![]() |
4.8%
|
4.5% |
Return on assets (ROA) |
15.5%
|
13.6%
|
18.5% |
Current ratio |
154.7%
|
144.4%
|
162.1% |
Return on equity (ROE) |
42.4%
|
43.8%
|
45.1% |
Change turnover |
5,578
|
2,705
|
5,993 |
Change turnover % |
37%
|
25%
|
99% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
20%
|
0%
|
67% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.